Global Cancer Biomarkers Market to Grow Exponentially to 2022, Predicts OMR in Its In-Demand Research Study Recently Added at MarketPublishers.com20 Apr 2017 • by Natalie Aster
LONDON – The world’s cancer biomarkers market is predicted to grow at the exponential rate, posting a CAGR of more than 11% from 2017 till 2022, encouraged by a wide range of favourable factors, including increased cancer incidence, growing awareness of biomarkers usage at various stages of cancer, dearth of physical activity, unhealthy diet, improper lifestyles, uncontrolled sun and UV exposure, surging consumption of tobacco.
Besides, enhancing demand for clinical diagnosis in early stages of cancer, rising geriatric population, surging adoption of biomarkers in surrogate endpoints and drug targets developments, strong interest among researches towards cancer diagnostics along with escalating necessity of the biomarkers in cancer research, technological innovations and advancements and mushrooming demand for personalized therapies are the top factors propelling growth of the world’s market.
Still, the cancer biomarkers market growth could be significantly restrained by high adoption costs, weak reimbursement policies and certain technical hurdles associated with both sample collection and storage.
Driven by significant government support for biomarkers discovery and development, enhancing adoption of biomarkers in drug discovery and development, and fast-evolving omics technology, North America is anticipated to remain the unrivalled leader in the global marketplace. In the offing, APAC is poised to witness growth at the highest rate given such growth driving forces as substantial government investments into cancer biomarkers research and increasing cancer incidence in the regional countries, to name only a few.
The comprehensive research report “Global Cancer Biomarkers Market Research and Analysis 2015-2022” prepared by Orion Market Research Private Limited (OMR) provides a detailed market analysis, comprising an overview of the key market determinants and estimations. The report delves into the market segmentation (in terms of biomarker types, tumor types, applications, profiling technologies, regions), offers detailed geographical and patent analyses, examines the market competitive environment (identifying about 20 dominant market participants), includes vital strategic recommendations. Additionally, the publication highlights new product developments and launches, geographic expansion, the latest mergers and acquisitions, key strategies adopted by the market players in the past few years. It also covers the market dynamics, focusing on the major growth drivers, challenges and hinders. Opportunities emerging in the market are also reviewed here. Forecasts up to 2022 are at hand in the report, too.
Other cutting-edge research reports by OMR are available at its page.